These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22840747)

  • 61. Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Katha UTA; Ashraf GM
    Curr Drug Targets; 2021; 22(14):1578-1584. PubMed ID: 33687894
    [No Abstract]   [Full Text] [Related]  

  • 62. Alzheimer's disease: therapeutic strategies for the 1990s.
    Pendlebury WW; Solomon PR
    Neurobiol Aging; 1994; 15(2):287-9. PubMed ID: 7838315
    [No Abstract]   [Full Text] [Related]  

  • 63. Advances of Alzheimer's disease research: crossroad of basic and translational studies.
    Lahiri DK
    Curr Alzheimer Res; 2005 Dec; 2(5):495-6. PubMed ID: 16375652
    [No Abstract]   [Full Text] [Related]  

  • 64. While I Still Remember: 30 Years of Alzheimer's Disease Research.
    Shea TB
    J Alzheimers Dis; 2018; 62(3):1049-1057. PubMed ID: 29226872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is angiogenesis a plausible hypothesis in Alzheimer's disease?
    Birkenhäger WH; Staessen JA
    J Hypertens; 2003 Jul; 21(7):1426-7. PubMed ID: 12817194
    [No Abstract]   [Full Text] [Related]  

  • 66. Inner Workings: A pulse of hope in the fight against Alzheimer's.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18142-18145. PubMed ID: 32669429
    [No Abstract]   [Full Text] [Related]  

  • 67. Sex and gender in Alzheimer's disease - Does it matter?
    Mielke MM; Ferretti MT; Iulita MF; Hayden K; Khachaturian AS
    Alzheimers Dement; 2018 Sep; 14(9):1101-1103. PubMed ID: 30196887
    [No Abstract]   [Full Text] [Related]  

  • 68. Sterilization techniques: Counter the risk of Alzheimer's transfer.
    Beekes M; Thomzig A
    Nature; 2016 Mar; 531(7596):580. PubMed ID: 27029268
    [No Abstract]   [Full Text] [Related]  

  • 69. Challenging views of Alzheimer's disease - round II.
    Kircher C
    Neurobiol Aging; 2004; 25(5):693-4. PubMed ID: 15172749
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical assessment of Alzheimer's disease.
    Morris JC
    Neurology; 1997 Sep; 49(3 Suppl 3):S7-10. PubMed ID: 9310506
    [No Abstract]   [Full Text] [Related]  

  • 71. Alzheimer's disease and cancer: the need of putting research into context with previous published systematic reviews.
    Catalá-López F; Tabarés-Seisdedos R
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):569-70. PubMed ID: 25143306
    [No Abstract]   [Full Text] [Related]  

  • 72. Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
    Verma A; Shteinfer-Kuzmine A; Kamenetsky N; Pittala S; Paul A; Nahon Crystal E; Ouro A; Chalifa-Caspi V; Pandey SK; Monsonego A; Vardi N; Knafo S; Shoshan-Barmatz V
    Transl Neurodegener; 2023 Jan; 12(1):2. PubMed ID: 36627723
    [No Abstract]   [Full Text] [Related]  

  • 73. Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
    Yu Y; Fedele G; Celardo I; Loh SHY; Martins LM
    Cell Death Dis; 2021 Jul; 12(8):720. PubMed ID: 34285196
    [No Abstract]   [Full Text] [Related]  

  • 74. Correction to Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.
    Pan Y; Omori K; Ali I; Tachikawa M; Terasaki T; Brouwer KLR; Nicolazzo JA
    Mol Pharm; 2021 Oct; 18(10):3928-3929. PubMed ID: 34478315
    [No Abstract]   [Full Text] [Related]  

  • 75. Correction to: New approaches to symptomatic treatments for Alzheimer's disease.
    Cummings J
    Mol Neurodegener; 2021 Apr; 16(1):21. PubMed ID: 33794947
    [No Abstract]   [Full Text] [Related]  

  • 76. Correction: Mitochondrial DNA variation in Alzheimer's disease reveals a unique microprotein called SHMOOSE.
    Miller B; Kim SJ; Mehta HH; Cao K; Kumagai H; Thumaty N; Leelaprachakul N; Braniff RG; Jiao H; Vaughan J; Diedrich J; Saghatelian A; Arpawong TE; Crimmins EM; Ertekin-Taner N; Tubi MA; Hare ET; Braskie MN; Décarie-Spain L; Kanoski SE; Grodstein F; Bennett DA; Zhao L; Toga AW; Wan J; Yen K; Cohen P;
    Mol Psychiatry; 2023 Apr; 28(4):1827. PubMed ID: 36658336
    [No Abstract]   [Full Text] [Related]  

  • 77. Metabolic Mechanisms Connecting Alzheimer's and Parkinson's Diseases: Potential Avenues for Novel Therapeutic Approaches.
    Colca JR; Finck BN
    Front Mol Biosci; 2022; 9():929328. PubMed ID: 35782864
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
    Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
    J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of TDP-43 in Alzheimer's Disease.
    Chang XL; Tan MS; Tan L; Yu JT
    Mol Neurobiol; 2016 Jul; 53(5):3349-3359. PubMed ID: 26081142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
    Shah RC; Matthews DC; Andrews RD; Capuano AW; Fleischman DA; VanderLugt JT; Colca JR
    Curr Alzheimer Res; 2014; 11(6):564-73. PubMed ID: 24931567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.